NF-κB signaling plays a critical role in cancer development and progression; constitutive activation of NF-κB pathway has been reported in different types of cancer, including multiple myeloma and acute myeloid leukemias [23, 24]. This evidence concerns the gene NFKB1 and acute myeloid leukemia.